ARWR
Arrowhead Pharmaceuticals Inc
NASDAQ: ARWR · HEALTHCARE · BIOTECHNOLOGY
$73.48
+4.18% today
Updated 2026-04-30
Market cap
$9.88B
P/E ratio
44.08
P/S ratio
9.05x
EPS (TTM)
$1.60
Dividend yield
—
52W range
$12 – $77
Volume
2.2M
Arrowhead Pharmaceuticals Inc (ARWR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
18.50%
Operating margin
15.50%
ROE
75.50%
ROA
14.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $595458.00 | $-19.00M | -1,135.71% | -3,439.94% | -3,190.35% |
| 2007 | $1.21M | $-29.93M | -874.84% | -3,141.43% | -2,477.70% |
| 2008 | $1.30M | $-27.09M | -1,039.80% | -2,685.89% | -2,078.65% |
| 2009 | $3.76M | $-19.31M | -139.91% | -520.47% | -513.77% |
| 2010 | $620097.00 | $-5.77M | -698.68% | -1,419.46% | -931.15% |
| 2011 | $296139.00 | $-3.13M | 9.51% | -3,319.48% | -1,056.56% |
| 2012 | $146875.00 | $-21.13M | -1,090.79% | -14,358.61% | -14,383.61% |
| 2013 | $290266.00 | $-31.14M | 100.00% | -8,471.29% | -10,729.22% |
| 2014 | $175000.00 | $-58.63M | 100.00% | -30,443.59% | -33,502.97% |
| 2015 | $382000.00 | $-91.94M | 100.00% | -25,124.08% | -24,068.29% |
| 2016 | $158333.00 | $-81.72M | 100.00% | -51,627.09% | -51,614.63% |
| 2017 | $31.41M | $-34.38M | 100.00% | -117.79% | -109.46% |
| 2018 | $16.14M | $-54.45M | 100.00% | -346.52% | -337.32% |
| 2019 | $168.80M | $67.97M | 100.00% | 36.25% | 40.27% |
| 2020 | $87.99M | $-84.55M | 100.00% | -105.87% | -96.09% |
| 2021 | $138.29M | $-140.85M | 100.00% | -107.77% | -101.85% |
| 2022 | $243.23M | $-176.49M | 100.00% | -73.39% | -72.56% |
| 2023 | $240.74M | $-205.28M | 94.81% | -85.16% | -85.27% |
| 2024 | $3.55M | $-599.49M | -423.66% | -16,927.06% | -16,882.37% |
| 2025 | $829.45M | $-1.63M | 97.12% | 11.86% | -0.20% |